Clinical Trials
3 trialsNCT03358017 2023-10-19
YAPPETIZER
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
NCT04045522 2021-07-20
Study on Bisphosphonates Targeting Triple-negative Breast Cancer
Shengjing Hospital
Unknown
NCT02595138 2015-11-03
Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer
ChineseAMS
Phase 3 Unknown